Medical and prescription costs continue to rise, and renewal season may have you searching for ways to respond. Trend is outpacing what you may have seen in the past, and large claims and specialty drugs — including GLP-1s and gene therapies — are putting pressure on both fully insured and self-funded plans. These costs are often not easy for a plan to control, and not every cost control solution is allowed, opening you up to legal or employee-relations challenges.
We’ve partnered with attorneys at Sandberg Phoenix to help you understand what you can do and what to watch for.
Medicare adds another layer. Depending on the size of your organization, the group health plan may need to remain the primary payer for active employees who are Medicare-eligible. That means offering incentives to move those employees off the plan can lead to legal consequences, even when it seems like a win for both sides.
There are several options that have been around for a while and newer ones gaining traction.
When faced with a large increase, you might feel pressure to move quickly on a solution that sounds promising, but remember that it’s important to build in time for due diligence. Our team offers a four-part framework for evaluating any cost containment solution, covering savings, impact on employees and what it takes to implement well. Clear communication with employees is one of the biggest factors in whether a change succeeds.
The full webinar goes deeper into how each option works, the compliance details that can trip you up and the Q&A from attendees. Simply fill out the form to get the recording sent directly to you.
Content sponsored by Sandberg Phoenix law firm. This update is not intended to be exhaustive, nor should any discussion or opinions be construed as legal, tax or financial advice. TrueNorth Companies recommends consulting with legal, tax or benefits professionals before making any decisions related to employee benefit plans.